Androgens Potentiate the Effects of Erythropoietin in the Treatment of Anemia of End-Stage Renal Disease
- 1 January 1991
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 17 (1) , 29-33
- https://doi.org/10.1016/s0272-6386(12)80246-0
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietinKidney International, 1989
- Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney.Journal of Clinical Investigation, 1988
- Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridizationBlood, 1988
- Anemia of end-stage renal disease (ESRD)Kidney International, 1985
- A Comparison of Androgens for Anemia in Patients on HemodialysisNew England Journal of Medicine, 1981
- CONTROLLED EVALUATION OF HEMODIALYSIS PATIENTS ON NANDROLONE DECANOATE (ND) VS TESTOSTERONE ENANTHATE (TE) (ANDROGENS AND DIALYSIS PATIENT)Asaio Journal, 1979
- A controlled trial of nandrolone decanoate in the treatment of uremic anemiaKidney International, 1977
- Effect of Nandrolone Decanoate on the Anemia of Chronic Hemodialysis PatientsNephron, 1977
- Effects of testosterone and erythropoietin on erythroid colony formation in human bone marrow culturesBlood, 1975
- Anemia of the Regular Hemodialysis Patient and its TreatmentNephron, 1974